If you loved our Explainer on Antimicrobial Resistance, you'll love this new summarised version. This short report takes you through the key BIA member companies working in the AMR space, and explains the cutting-edge work taking place in the UK.
Welcome to our new-look quarterly report, where the BIA team share examples of the influence we are delivering for members on government policy and the global life sciences ecosystem.
The agreement is expected to serve as a critical foundation for activating international joint research, academic exchange and research collaboration in quantum fields, including quantum computing.
The workshop brought together leading academic researchers, industry experts and innovators to explore the fundamentals of AlphaFold – an artificial intelligence (AI) program developed by Google DeepMind to predict the 3D structure of proteins.
Cancer Research Horizons has announced a collaboration with Histofy to develop tools that predict how colorectal cancer patients respond to different treatment options using the multi-modal S:CORT dataset.
Multiomic Health and Alloy Therapeutics, Inc. have today announced a collaboration to discover and develop renal tissue-targeting drugs. The collaboration provides external validation of MultiOmic Health’s AI-enabled precision medicine discovery platform and innovative renal therapeutic programs.
Last week, we were delighted to launch the new Functional Genomics Screening Laboratory (FGSL) here at the Milner Therapeutics Institute in Cambridge, UK.
